Invention Grant
US08388995B1 Controlled and extended delivery of hyaluronic acid and comfort molecules via a contact lens platform
有权
通过隐形眼镜平台控制和延长透明质酸和舒适分子的输送
- Patent Title: Controlled and extended delivery of hyaluronic acid and comfort molecules via a contact lens platform
- Patent Title (中): 通过隐形眼镜平台控制和延长透明质酸和舒适分子的输送
-
Application No.: US12395394Application Date: 2009-02-27
-
Publication No.: US08388995B1Publication Date: 2013-03-05
- Inventor: Maryam Ali , Mark E. Byrne
- Applicant: Maryam Ali , Mark E. Byrne
- Applicant Address: US AL Auburn
- Assignee: Auburn University
- Current Assignee: Auburn University
- Current Assignee Address: US AL Auburn
- Agency: McKee, Voorhees & Sease, P.L.C.
- Main IPC: A61K9/00
- IPC: A61K9/00

Abstract:
A drug delivery system is disclosed. The drug delivery system includes a recognitive polymeric hydrogel through which a drug is delivered by contacting biological tissue. The recognitive polymeric hydrogel is formed using a bio-template, which is a drug or is structurally similar to the drug, functionalized monomers, preferably having complexing sites, and cross-linking monomers, which are copolymerized using a suitable initiator. The complexing sites of the recognitive polymeric hydrogel that is formed mimic receptor sites of a target biological tissue, biological recognition, or biological mechanism of action. A system in accordance with some embodiments is a contact lens for delivering a drug through contact with an eye. In some embodiments, the drug is an anti-microbial, such as an anti-fungal agent for treatment of large animals. In some embodiments, a comfort molecule hyaluronic acid (HA) is delivered. In some embodiments, ketotifen fumarate (anti-histamine) and/or diclofenac sodium (anti-inflammatory) are delivered.
Information query